$61.82
0.02% yesterday
NYSE, Aug 12, 10:00 pm CET
ISIN
US26622P1075
Symbol
DOCS

Doximity Stock price

$61.82
+0.27 0.44% 1M
-13.36 17.77% 6M
+8.43 15.79% YTD
+26.87 76.88% 1Y
+23.84 62.77% 3Y
+8.82 16.64% 5Y
+8.82 16.64% 10Y
+8.82 16.64% 20Y
NYSE, Closing price Tue, Aug 12 2025
-0.01 0.02%
ISIN
US26622P1075
Symbol
DOCS

Key metrics

Basic
Market capitalization
$11.6b
Enterprise Value
$10.7b
Net debt
positive
Cash
$915.7m
Shares outstanding
188.9m
Valuation (TTM | estimate)
P/E
55.7 | 42.8
P/S
20.3 | 18.1
EV/Sales
18.7 | 16.7
EV/FCF
40.0
P/B
10.7
Financial Health
Equity Ratio
85.6%
Return on Equity
20.6%
ROCE
20.8%
ROIC
88.5%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$570.4m | $638.8m
EBITDA
$240.8m | $347.4m
EBIT
$230.1m | $339.8m
Net Income
$223.2m | $272.9m
Free Cash Flow
$266.7m
Growth (TTM | estimate)
Revenue
20.0% | 12.0%
EBITDA
39.3% | 44.3%
EBIT
33.9% | 47.7%
Net Income
51.2% | 22.3%
Free Cash Flow
49.6%
Margin (TTM | estimate)
Gross
90.2%
EBITDA
42.2% | 54.4%
EBIT
40.3%
Net
39.1% | 42.7%
Free Cash Flow
46.8%
More
EPS
$1.1
FCF per Share
$1.4
Short interest
3.7%
Employees
827
Rev per Employee
$690.0k
Show more

Is Doximity a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Doximity Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Doximity forecast:

15x Buy
58%
11x Hold
42%

Analyst Opinions

26 Analysts have issued a Doximity forecast:

Buy
58%
Hold
42%

Financial data from Doximity

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
570 570
20% 20%
100%
- Direct Costs 56 56
10% 10%
10%
515 515
21% 21%
90%
- Selling and Administrative Expenses 191 191
12% 12%
33%
- Research and Development Expense 93 93
13% 13%
16%
241 241
39% 39%
42%
- Depreciation and Amortization 11 11
906% 906%
2%
EBIT (Operating Income) EBIT 230 230
34% 34%
40%
Net Profit 223 223
51% 51%
39%

In millions USD.

Don't miss a Thing! We will send you all news about Doximity directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Doximity Stock News

Neutral
Seeking Alpha
5 days ago
Doximity, Inc. (NYSE:DOCS ) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Perry Scott Gold - Head of Investor Relations Conference Call Participants Allen Charles Lutz - BofA Securities, Research Division Brian Christopher Peterson - Raymond James & Associates, Inc., Resear...
Neutral
The Motley Fool
5 days ago
Doximity (DOCS) Q1 Revenue Rises 15%
Positive
CNBC
5 days ago
Doximity has acquired the AI startup Pathway Medical for $63 million.  Pathway has one of the largest structured datasets in medicine, Doximity said.
More Doximity News

Company Profile

Doximity, Inc. operates an online platform for medical professionals. It's cloud-based software has the ability to enable the users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. The company was founded by Konstantin Guericke, Nate Gross and Jeffrey A. Tangney in April 16, 2010 and is headquartered in San Francisco, CA.

Head office United States
CEO Jeffrey Tangney
Employees 827
Founded 2010
Website www.doximity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today